Retinal Disorder Treatment Market Size, Share & Trends Analysis Report By Type (Macular Degeneration, Diabetic Retinopathy), By Dosage Form, By Distribution Channel, By Product Type, And Segment Forecasts, 2019 - 2026

Published: Oct, 2019 | Pages: 90 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global retinal disorder treatment market size is expected to reach USD 15.8 billion by 2026, according to a new report by Grand View Research, Inc., registering a CAGR of 7.6% over the forecast period. Increasing prevalence and incidence of retinal disorders is considered to be the primary growth driver.

According to data published in the NCBI in 2018, around 18.0% of diabetic patients in India suffer from diabetic retinopathy. Similarly, National Eye Institute estimates that by 2030 and 2050, around 10 and 14 million people respectively will suffer from diabetic retinopathy in America. Based on an article published by WebMD in 2019, age-related macular degeneration (AMD) is the leading cause of irreversible visual loss in U.S., occurring in more than 10% of the population aged 65-74 years. Moreover, the NCBI estimates that by 2040, individuals with early and late AMD will range between 14.9-21.5 million and 3.9-4.8 million respectively in Europe.

Increasing geriatric population is also anticipated to be a major factor governing the overall market. According to data published in the World Population Prospects: 2019 Revision, around 1 in 11 and 1 in 4 people living in North America and Europe, respectively, will be aged 65 years and above by 2050.

Growing awareness of retinal disorders is also expected to propel market growth over the forecast period. For instance, the Institut de la Macula started an awareness campaign on age-related macular degeneration in 2019. The primary aim of this campaign is to create awareness about the disease, benefits of early detection, and available treatment options in the market.

Further key findings from the report suggest:

• By type, macular degeneration held the dominant share in 2018 and is estimated to be the fastest growing segment over the forecast period. Rising prevalence of macular degeneration globally is the major factor driving the segment

• In 2018, dry macular degeneration emerged as the largest segment and is expected to register the highest CAGR through 2026

• On the basis of dosage form, eye solutions formed the leading segment in 2018. Eye drops are estimated to be the fastest growing segment over the forecast period owing to strong presence of pipeline products

• Based on distribution channel, hospital pharmacies held the largest share in 2018 while online pharmacy will exhibit the fastest growth by 2026

• North America held the dominant revenue share in 2018 owing to presence of key players in the market. Asia Pacific is estimated to witness the fastest CAGR of 9.5% from 2019 to 2026

• Research and development and collaborations are some of the crucial strategies adopted by players in the market.

 Table of Contents

Chapter 1. Methodology and Scope
                  1.1. Market segmentation & scope
                  1.2. Information procurement
                      1.2.1. Purchased database
                      1.2.2. GVR's internal database
                      1.2.3. Secondary sources & third party perspectives
                      1.2.4. Primary research
                  1.3. Information analysis
                      1.3.1. Data analysis models
                  1.4. Market formulation & data visualization
                  1.5. Data validation & publishing

Chapter 2. Executive Summary
                  2.1. Market Outlook
                  2.2. Segment Outlook
                  2.3. Competitive Insights

Chapter 3. Retinal Disorder Treatment Market Variables, Trends & Scope
                  3.1. Market Lineage outlook
                      3.1.1. Parent market outlook
                      3.1.2. Related/ancillary market outlook
                  3.2. Penetration & Growth Prospect Mapping
                  3.3. Pipeline Analysis, by Stage
                  3.4. Market Dynamics
                      3.4.1. Market Driver Analysis
                          3.4.1.1. Increasing prevalence of retinal disorders
                          3.4.1.2. Presence of pipeline products
                          3.4.1.3. Increasing geriatric population
                          3.4.1.4. Rising awareness of retinal disorders
                      3.4.2. Market Restraint Analysis
                          3.4.2.1. High cost of treatment drugs
                  3.5. Retinal disorder treatment: Market Analysis Tools
                      3.5.1. Industry Analysis - Porter's
                          3.5.1.1. Supplier Power (Moderate due to large number of manufacturers)
                          3.5.1.2. Buyer Power (High due to increasing prevalence of retinal disorders)
                          3.5.1.3. Substitution Threat (High due to presence external substitutes)
                          3.5.1.4. Threat from new entrant (Moderate due to brand recognition of the existing players)
                          3.5.1.5. Competitive rivalry (High due to rigorous competition among key players)
                      3.5.2. PESTEL Analysis
                          3.5.2.1. Political Landscape
                          3.5.2.2. Environmental Landscape
                          3.5.2.3. Social Landscape
                          3.5.2.4. Technology Landscape
                          3.5.2.5. Legal Landscape
                      3.5.3. Major Deals & Strategic Alliances Analysis
                          3.5.3.1. Joint Ventures
                          3.5.3.2. Mergers & Acquisitions
                          3.5.3.3. Licensing & Partnership
                          3.5.3.4. Technology Collaborations
                          3.5.3.5. Strategic Divestments

Chapter 4. Retinal Disorder Treatment Market: Segment Analysis, By Type, 2014 - 2026 (USD Million)
                  4.1. Definitions & Scope
                  4.2. Type Market Share Analysis, 2018 & 2026
                  4.3. Segment Dashboard
                  4.4. Global Retinal Disorder Treatment Market, By Type, 2014 to 2026
                  4.5. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following
                      4.5.1. Macular Degeneration
                          4.5.1.1. Dry Macular Degeneration
                          4.5.1.2. Wet Macular Degeneration
                      4.5.2. Diabetic Retinopathy
                      4.5.3. Others

Chapter 5. Retinal Disorder Treatment Market: Segment Analysis, By Dosage Form, 2014 - 2026 (USD Million)
                  5.1. Definitions & Scope
                  5.2. Dosage Form Market Share Analysis, 2018 & 2026
                  5.3. Segment Dashboard
                  5.4. Global Retinal Disorder Treatment Market, By Dosage Form, 2014 to 2026
                  5.5. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following
                      5.5.1. Gels
                      5.5.2. Eye Solutions
                      5.5.3. Capsules & Tablets
                      5.5.4. Eye drops
                      5.5.5. Ointments

Chapter 6. Retinal Disorder Treatment Market: Segment Analysis, By Distribution Channel, 2014 - 2026 (USD Million)
                  6.1. Definitions & Scope
                  6.2. Distribution Channel Market Share Analysis, 2018 & 2026
                  6.3. Segment Dashboard
                  6.4. Global Retinal Disorder Treatment Market, By Distribution Channel, 2014 to 2026
                  6.5. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following
                      6.5.1. Hospital Pharmacy
                      6.5.2. Online Pharmacy
                      6.5.3. Retail Pharmacy

Chapter 7. Retinal Disorder Treatment Market: Regional Market Analysis, By Region, 2014 - 2026 (USD Million)
                  7.1. Definitions & Scope
                  7.2. Regional Market Share Analysis, 2018 & 2026
                  7.3. Regional Market Dashboard
                  7.4. Regional Market Share and Leading Players, 2018
                  7.5. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
                      7.5.1. North America
                      7.5.2. Europe
                      7.5.3. Asia Pacific
                      7.5.4. Latin America
                      7.5.5. Middle East & Africa
                  7.6. Market Size, & Forecasts and Trend Analysis, 2019 to 2026:
                  7.7. North America
                      7.7.1. Market estimates and forecast, by country, 2014 - 2026 (USD Million)
                      7.7.2. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                      7.7.3. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                      7.7.4. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.7.5. U.S.
                          7.7.5.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.7.5.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.7.5.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.7.6. Canada
                          7.7.6.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.7.6.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.7.6.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                  7.8. Europe
                      7.8.1. Market estimates and forecast, by country, 2014 - 2026 (USD Million)
                      7.8.2. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                      7.8.3. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                      7.8.4. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.8.5. Germany
                          7.8.5.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.8.5.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.8.5.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.8.6. U.K.
                          7.8.6.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.8.6.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.8.6.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.8.7. France
                          7.8.7.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.8.7.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.8.7.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.8.8. Italy
                          7.8.8.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.8.8.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.8.8.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.8.9. Spain
                          7.8.9.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.8.9.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.8.9.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.8.10. Russia
                          7.8.10.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.8.10.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.8.10.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                  7.9. Asia Pacific
                      7.9.1. Market estimates and forecast, by country, 2014 - 2026 (USD Million)
                      7.9.2. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                      7.9.3. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                      7.9.4. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.9.5. China
                          7.9.5.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.9.5.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.9.5.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.9.6. Japan
                          7.9.6.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.9.6.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.9.6.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.9.7. India
                          7.9.7.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.9.7.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.9.7.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.9.8. South Korea
                          7.9.8.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.9.8.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.9.8.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.9.9. Singapore
                          7.9.9.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.9.9.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.9.9.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.9.10. Australia
                          7.9.10.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.9.10.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.9.10.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                  7.10. Latin America
                      7.10.1. Market estimates and forecast, by country, 2014 - 2026 (USD Million)
                      7.10.2. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                      7.10.3. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                      7.10.4. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.10.5. Brazil
                          7.10.5.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.10.5.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.10.5.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.10.6. Mexico
                          7.10.6.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.10.6.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.10.6.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.10.7. Argentina
                          7.10.7.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.10.7.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.10.7.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                  7.11. Middle East and Africa
                      7.11.1. Market estimates and forecast, by country, 2014 - 2026 (USD Million)
                      7.11.2. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                      7.11.3. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                      7.11.4. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.11.5. South Africa
                          7.11.5.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.11.5.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.11.5.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.11.6. Saudi Arabia
                          7.11.6.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.11.6.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.11.6.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)
                      7.11.7. UAE
                          7.11.7.1. Market estimates and forecast, by type, 2014 - 2026 (USD Million)
                          7.11.7.2. Market estimates and forecast, by dosage form, 2014 - 2026 (USD Million)
                          7.11.7.3. Market estimates and forecast, by distribution channel, 2014 - 2026 (USD Million)

Chapter 8. Retinal Disorder Treatment Market - Competitive Analysis
                  8.1. Recent developments & impact analysis, by key market participants
                  8.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
                  8.3. Public Companies
                      8.3.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
                      8.3.2. Company Market Share/Ranking, by region
                      8.3.3. Competitive Dashboard Analysis
                  8.4. Private Companies
                      8.4.1. List of key emerging companies' /technology disruptors/innovators
                      8.4.2. Regional network map
                      8.4.3. Company market position analysis
                  8.5. Key companies profiled
                      8.5.1. Santen Pharmaceutical Co., Ltd.
                          8.5.1.1. Company Overview
                          8.5.1.2. Financial Performance
                          8.5.1.3. Product Benchmarking
                          8.5.1.4. Strategic Initiatives
                      8.5.2. REGENERON
                          8.5.2.1. Company Overview
                          8.5.2.2. Financial Performance
                          8.5.2.3. Product Benchmarking
                          8.5.2.4. Strategic Initiatives
                      8.5.3. Graybug Vision, Inc.
                          8.5.3.1. Company Overview
                          8.5.3.2. Financial Performance
                          8.5.3.3. Product Benchmarking
                          8.5.3.4. Strategic Initiatives
                      8.5.4. Shire (Takeda Pharmaceutical Company Limited)
                          8.5.4.1. Company Overview
                          8.5.4.2. Financial Performance
                          8.5.4.3. Product Benchmarking
                          8.5.4.4. Strategic Initiatives
                      8.5.5. Bayer AG
                          8.5.5.1. Company Overview
                          8.5.5.2. Financial Performance
                          8.5.5.3. Product Benchmarking
                          8.5.5.4. Strategic Initiatives
                      8.5.6. Genentech, Inc.
                          8.5.6.1. Company Overview
                          8.5.6.2. Financial Performance
                          8.5.6.3. Product Benchmarking
                          8.5.6.4. Strategic Initiatives
                      8.5.7. Acucela Inc.
                          8.5.7.1. Company Overview
                          8.5.7.2. Financial Performance
                          8.5.7.3. Product Benchmarking
                          8.5.7.4. Strategic Initiatives
                      8.5.8. Pfizer, Inc.
                          8.5.8.1. Company Overview
                          8.5.8.2. Financial Performance
                          8.5.8.3. Product Benchmarking
                          8.5.8.4. Strategic Initiatives

List of Tables

TABLE 1 List of Abbreviation
TABLE 2 North America Retinal Disorder Treatment Market, By Country, 2014 - 2026 (USD Million)
TABLE 3 North America Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 4 North America Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 5 North America Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 6 North America Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 7 U.S. Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 8 U.S. Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 9 U.S. Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 10 U.S. Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 11 Canada Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 12 Canada Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 13 Canada Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 14 Canada Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 15 Europe Retinal Disorder Treatment Market, By Country, 2014 - 2026 (USD Million)
TABLE 16 Europe Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 17 Europe Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 18 Europe Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 19 Europe Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 20 U.K. Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 21 U.K. Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 22 U.K. Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 23 U.K. Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 24 Germany Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 25 Germany Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 26 Germany Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 27 Germany Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 28 France Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 29 France Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 30 France Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 31 France Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 32 Italy Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 33 Italy Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 34 Italy Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 35 Italy Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 36 Spain Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 37 Spain Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 38 Spain Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 39 Spain Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 40 Russia Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 41 Russia Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 42 Russia Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 43 Russia Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 44 Asia Pacific Retinal Disorder Treatment Market, By Country, 2014 - 2026 (USD Million)
TABLE 45 Asia Pacific Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 46 Asia Pacific Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 47 Asia Pacific Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 48 Asia Pacific Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 49 Japan Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 50 Japan Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 51 Japan Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 52 Japan Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 53 China Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 54 China Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 55 China Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 56 China Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 57 India Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 58 India Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 59 India Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 60 India Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 61 South Korea Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 62 South Korea Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 63 South Korea Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 64 South Korea Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 65 Singapore Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 66 Singapore Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 67 Singapore Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 68 Singapore Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 69 Australia Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 70 Australia Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 71 Australia Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 72 Australia Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 73 Latin America Retinal Disorder Treatment Market, By Country, 2014 - 2026 (USD Million)
TABLE 74 Latin America Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 75 Latin America Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 76 Latin America Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 77 Latin America Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 78 Mexico Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 79 Mexico Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 80 Mexico Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 81 Mexico Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 82 Brazil Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 83 Brazil Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 84 Brazil Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 85 Brazil Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 86 Argentina Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 87 Argentina Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 88 Argentina Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 89 Argentina Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 90 MEA Retinal Disorder Treatment Market, By Country, 2014 - 2026 (USD Million)
TABLE 91 MEA Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 92 MEA Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 93 MEA Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 94 MEA Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 95 South Africa Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 96 South Africa Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 97 South Africa Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 98 South Africa Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 99 Saudi Arabia Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 100 Saudi Arabia Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 101 Saudi Arabia Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 102 Saudi Arabia Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
TABLE 103 UAE Retinal Disorder Treatment Market, By Type, 2014 - 2026 (USD Million)
TABLE 104 UAE Macular Degeneration Market, By Type, 2014 - 2026 (USD Million)
TABLE 105 UAE Retinal Disorder Treatment Market, By Dosage Form, 2014 - 2026 (USD Million)
TABLE 106 UAE Retinal Disorder Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Market summary
FIG. 4 Market segmentation & scope
FIG. 5 Market size and growth prospects
FIG. 6 Global retinal disorder treatment market - Key market driver analysis
FIG. 7 Global retinal disorder treatment market - Key market restraint analysis
FIG. 8 Penetration & growth prospect mapping
FIG. 9 Global retinal disorder treatment market - Porter's analysis
FIG. 10 Global retinal disorder treatment market - PESTEL analysis
FIG. 11 Global retinal disorder treatment market type outlook key takeaways
FIG. 12 Global retinal disorder treatment market: Type movement analysis
FIG. 13 Macular degeneration market estimates, 2014 - 2026 (USD Million)
FIG. 14 Dry macular degeneration market estimates, 2014 - 2026 (USD Million)
FIG. 15 Wet macular degeneration market estimates, 2014 - 2026 (USD Million)
FIG. 16 Diabetic retinopathy market estimates, 2014 - 2026 (USD Million)
FIG. 17 Others market estimates, 2014 - 2026 (USD Million)
FIG. 18 Global retinal disorder treatment market Dosage form outlook key takeaways
FIG. 19 Global retinal disorder treatment market: Dosage form movement analysis
FIG. 20 Gels market estimates, 2014 - 2026 (USD Million)
FIG. 21 Eye solutions market estimates, 2014 - 2026 (USD Million)
FIG. 22 Capsules & Tablets market estimates, 2014 - 2026 (USD Million)
FIG. 23 Eye drops market estimates, 2014 - 2026 (USD Million)
FIG. 24 Ointments market estimates, 2014 - 2026 (USD Million)
FIG. 25 Global retinal disorder treatment market Distribution channel outlook key takeaways
FIG. 26 Global retinal disorder treatment market: Distribution channel movement analysis
FIG. 27 Hospital pharmacy market estimates, 2014 - 2026 (USD Million)
FIG. 28 Online pharmacy market estimates, 2014 - 2026 (USD Million)
FIG. 29 Retail pharmacy market estimates, 2014 - 2026 (USD Million)
FIG. 30 Regional marketplace: Key takeaways
FIG. 31 Global retinal disorder treatment market: Regional movement analysis
FIG. 32 North America retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 33 U.S. retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 34 Canada retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 35 Europe retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 36 U.K. retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 37 Germany retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 38 France retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 39 Italy retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 40 Spain retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 41 Russia retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 42 Asia Pacific retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 43 Japan retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 44 China retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 45 India retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 46 South Korea retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 47 Singapore retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 48 Australia retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 49 Latin America retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG 50 Brazil retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 51 Mexico retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 52 Argentina retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 53 MEA retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 54 South Africa retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 55 Saudi Arabia retinal disorder treatment market, 2014 - 2026 (USD Million)
FIG. 56 UAE retinal disorder treatment